Let-7b acts as a tumor suppressor in osteosarcoma via targeting IGF1R

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• MicroRNAs regulate gene expression and are implicated in cancer progression.
• The specific role of Let-7b in osteosarcoma (OS) and its regulatory targets remain largely uncharacterized.
• Understanding microRNA functions is key to developing novel cancer therapies.

Purpose of the Study:

• To investigate the function of Let-7b in osteosarcoma.
• To elucidate the regulatory relationship between Let-7b and the insulin-like growth factor 1 receptor (IGF1R).
• To explore the potential of the Let-7b/IGF1R axis as a therapeutic target in OS.

Main Methods:

• Quantitative real-time PCR to assess Let-7b expression in OS tissues and cell lines.
• Cell proliferation and invasion assays (U2OS, SAOS-2) following Let-7b overexpression.
• Luciferase reporter assays to confirm IGF1R as a direct target of Let-7b.
• Western blotting to evaluate IGF1R protein levels.

Main Results:

• Let-7b was significantly downregulated in osteosarcoma tissues and cell lines.
• Overexpression of Let-7b inhibited osteosarcoma cell proliferation and invasion.
• IGF1R was validated as a direct downstream target of Let-7b, with Let-7b decreasing IGF1R expression.
• IGF1R was upregulated in OS tissues and inversely correlated with Let-7b levels.

Conclusions:

• Let-7b functions as a tumor suppressor in osteosarcoma by targeting and downregulating IGF1R.
• The Let-7b/IGF1R axis represents a novel therapeutic target for anti-metastasis strategies in osteosarcoma.
• Let-7b may serve as a potential prognostic biomarker for osteosarcoma.